Physician profile
Donna M Cagle
NPI 1205978194
$557.90
in general payments reported to CMS, 2019-2025
8 companies · $400 in 2025
The $400 reported for 2025 was more than what 97% of Ambulatory Care providers received nationally (typical 2025 total: $68.82).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $33.44 · 2023: $46.18 · 2024: $78.01 · 2025: $400.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $524.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $524.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $306.50 | 2023-2025 | Annovera, Nextstellis, Bijuva |
| Astellas Pharma US INC | $89.05 | 2024-2025 | Veozah |
| Millicent US INC | $40.80 | 2025 | Femlyv, Intrarosa |
| Organon LLC | $34.78 | 2025 | Nexplanon |
| Sage Therapeutics, LLC | $31.21 | 2025 | Zurzuvae |
| Exeltis, USA INC. | $22.12 | 2024 | Slynd |
| Therapeuticsmd, INC. | $18.37 | 2022 | |
| Evofem Biosciences, INC. | $15.07 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donna Cagle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.